ライフサイエンスコーパス: metastasizing

1 l cancer cells within a tumor are capable of metastasizing.

2 d to assess patient prognosis and to prevent metastasizing.

3 luence could reduce the chance of a melanoma metastasizing.

4 an dramatically accelerate tumorigenesis and metastasizing ability of prostate cancer cells.

5 expression was virtually diminished, and the metastasizing ability was lost after cells were stably t

6 d cells to acquire estrogen independence and metastasizing ability.

7 elial cell line, Rama 37, yields benign, non-metastasizing adenomatous tumours in syngeneic Furth-Wis

8 exus required for the survival and growth of metastasizing and circulating tumor cells in vivo.

9 our screening study comparing mRNA levels in metastasizing and nonmetastasizing endometrial carcinoma

10 hether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was stil

11 fferentiated disease into a more aggressive, metastasizing, and fatal malignancy.

12 (SCLC) is an aggressive, rapidly growing and metastasizing, and highly fatal neoplasm.

13 sed in invasive breast carcinomas capable of metastasizing, and it may be clinically useful in patien

14 In a mouse model of spontaneously metastasizing breast cancer (MMTV-PyV mT), we found that

15 line with genomic DNA fragments from a human metastasizing breast cancer cell line yields cells which

16 onmental cues in the regulation of miRNAs in metastasizing cancer cells has not been studied.

17 Whether metastasizing cancer cells reach lymph nodes via intratu

18 ese results suggest that host B7x may enable metastasizing cancer cells to escape local antitumor imm

19 The reduction in miR-193b enabled the metastasizing cancer cells to invade and proliferate int

20 ntoic membrane (CAM), and mRNA levels in the metastasizing cancer cells were evaluated by species-spe

21 ay lead to changes in gene expression of the metastasizing cancer cells, although such changes have n

22 and even less is known about the identity of metastasizing cancer cells.

23 a mimicry of skeletal cellular phenotypes by metastasizing cancer cells.

24 ick, adaptable switch to promote survival of metastasizing cancer cells.

25 potential therapeutic target for lung-tropic metastasizing cancers.

26 of lymphovascular invasion exhibited by all metastasizing cancers.

27 After separating from a primary tumor, metastasizing cells enter the circulatory system and int

28 ove cancer therapy, it is critical to target metastasizing cells.

29 known to be elevated in patients with liver-metastasizing colon cancer; thus, cholecystokinin (CCK)

30 on and LOH of genes on chromosome 3 occur in metastasizing disomy 3 UM and are detectable by aSNP ana

31 f chromosome 3 were seen in the remaining 17 metastasizing disomy 3 UMs by MLPA.

32 etastasizing monosomy 3 uveal melanoma; iii) metastasizing disomy 3 uveal melanoma; and iv) monosomy

33 play a dominant role by invading further and metastasizing earlier.

34 Metastasizing EOCs engage in integrin-mediated adhesion

35 ring epithelial-to-mesenchymal transition of metastasizing epithelial tumors, we generated citrullina

36 f g-E and g-EAR delayed bioluminescence from metastasizing ES-2-luc cells for 2 and 3weeks, respectiv

37 tly, an in vivo model of human breast cancer metastasizing from the orthotopic site to bone does not

38 ancers, it inhibits primary lung tumors from metastasizing in a mouse model system.

39 in real time, fluorescent tumors growing and metastasizing in live mice.

40 tatic lesions to the oral mucosa; only cases metastasizing in the oral mucosa, gingiva, and periodont

41 Benign metastasizing leiomyoma (BML) is a rare condition descri

42 ction with the diagnosis of pulmonary benign metastasizing leiomyoma being stated.

43 We present a case of pulmonary benign metastasizing leiomyoma in a female patient admitted to

44 Pulmonary benign metastasizing leiomyoma is a rare entity.

45 es confirmed the initial diagnosis of benign metastasizing leiomyoma with no evidence of neoplastic c

46 age peptides home may serve as receptors for metastasizing malignant cells.

47 T1 tumor, a highly aggressive, spontaneously metastasizing mammary carcinoma, followed by surgical re

48 Among the 71 patients who had died of metastasizing melanoma, there was no difference in time

49 Monosomy 3 was detected in 47 of 71 metastasizing melanomas (66.1%) and was significantly as

50 Successfully metastasizing melanomas underwent reversible metabolic c

51 plantation, particularly among inefficiently metastasizing melanomas.

52 uveal melanoma with long-term survival; ii) metastasizing monosomy 3 uveal melanoma; iii) metastasiz

53 gene expression signature for distinguishing metastasizing (N+) from nonmetastasizing (N0) squamous c

54 ioleiomyomatosis (LAM) is a rare, low-grade, metastasizing neoplasm that arises from an unknown sourc

55 the view of LAM as a low-grade, destructive, metastasizing neoplasm.

56 y as those caused by low-grade or high-grade metastasizing neoplasms, polyclonal or monoclonal lympho

57 Because of the intimate relationship between metastasizing neoplastic cells and vascular as well as e

58 on of a tumor suppressor miRNA, miR-193b, in metastasizing OvCa cells.

59 ically promotes the invasive ability of bone-metastasizing prostate (and breast) cancer cells but not

60 type are indistinguishable from those of the metastasizing prostate tumors but distinctly different f

61 nesis in vivo remains poor, in particular in metastasizing solid cancers.

62 eatment of hematologic malignancies and bone-metastasizing solid tumors.

63 Higher levels of LRV-1 in metastasizing strains of L.V. guyanensis have been docum

64 array of cell membrane molecules on a liver-metastasizing subline of B16 melanoma versus the parenta

65 Prostate carcinoma cells metastasizing to bone must initially adhere to endotheli

66 or osteolytic lesions caused by cancer cells metastasizing to bone.

67 The lowest T category tumor metastasizing to both regional nodes and distant locatio

68 m the ECM are capable of evading anoikis and metastasizing to different distant organs.

69 fest distinct gene expression patterns after metastasizing to different organs.

70 t melanoma is highly invasive and capable of metastasizing to distant sites where it is typically res

71 in syngeneic C57Bl/6 mice, which form tumors metastasizing to draining lymph nodes and subsequently t

72 was inhibited, and the number of tumor cells metastasizing to lung was reduced significantly by combi

73 ly fluorescent pancreatic tumors growing and metastasizing to multiple sites in live mice.

74 c lesions to the gingiva compared with cases metastasizing to other oral mucosal sites.

75 Tumors metastasizing to the CNS and leptomeninges (LM) are asso

76 inal tract origin, have a predisposition for metastasizing to the liver.

77 This mechanotransduced pathway may regulate metastasizing tumor cell adhesion.

78 A mutual relationship exists between metastasizing tumor cells and components of the coagulat

79 contribute to the close association between metastasizing tumor cells and peri-tumor lymphatic densi

80 Importantly, the omentum collects metastasizing tumor cells and supports tumor growth by i

81 Reduced recruitment of monocytes to metastasizing tumor cells in Fuc-TVII(-/-) mice correlat

82 Thus, the recruitment of monocytes to metastasizing tumor cells is facilitated by endogenous s

83 Metastasizing tumor cells migrate through the surroundin

84 rise from a multi-step process that requires metastasizing tumor cells to adapt to signaling input fr

85 , may enable a molecular mimicry that allows metastasizing tumor cells to downregulate MHC class I, t

86 As metastasizing tumor cells undergo epithelial to mesenchy

87 Metastasizing tumor cells use matrix metalloproteases, s

88 The recruitment of inflammatory monocytes to metastasizing tumor cells was dependent on the local end

89 s critically dependent on the interaction of metastasizing tumor cells with cells in the local microe

90 PMo established early interactions with metastasizing tumor cells, scavenged tumor material from

91 ns regulates migratory and invasive nexus of metastasizing tumor cells.

92 veloping insect embryos, skeletal muscle and metastasizing tumor cells.

93 reast) cancer cells but not that of non-bone-metastasizing tumor cells.

94 n vivo cancer cell tracking in spontaneously metastasizing tumor models still poses a challenge requi

95 arcinoma differs from that of hematogenously metastasizing tumors because ovarian cancer cells primar

96 ne confers the ability to form spontaneously metastasizing tumors in ovariectomized nude mice without

97 Median pO2 was 7.5 mm Hg for metastasizing tumors versus 20 mm Hg for nonmetastasizin

98 BAP1) on chromosome 3p21.1 in 26 of 31 (84%) metastasizing tumors, including 15 mutations causing pre

99 ogically normal prostate tissues surrounding metastasizing tumors.

100 iated macrophages and their interaction with metastasizing tumour cells, is dependent on CCL2 synthes

101 16 genes showed LOH exclusively in disomy 3 metastasizing UM, suggesting a potential role for these

102 ozen tissue samples from four fatal disomy 3 metastasizing UMs and three disomy 3 tumors with >5 year

103 Two metastasizing UMs that had been classified as disomy 3 b

104 gosity (LOH) on chromosome 3 in the disomy 3 metastasizing UMs that were not deleted or showing LOH i

105 (FFPE) whole tumor sections from 19 disomy 3 metastasizing UMs.

106 ng finding of our study was that even before metastasizing, VEGF-A-overexpressing primary tumors indu